Cutoff levels of 17-α-hydroxyprogesterone in neonatal screening for congenital adrenal hyperplasia should be based on gestational age rather than on birth weight

Journal of Clinical Endocrinology and Metabolism

Volumn 90, Issue 7, 2005, Pages 3904-3907

  Van Der Kamp, Hetty J ^a   Oudshoorn, Caren G M ^b   Elvers, Bert H ^c   Van Baarle, Maja ^d   Otten, Barto J ^e   Wit, Jan M ^a   Verkerk, Paul H ^b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b TNO   (Netherlands)

^c NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^d IJSSELLAND HOSPITAL   (Netherlands)

^e RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYPROGESTERONE;

ARTICLE; BIRTH WEIGHT; BLOOD SAMPLING; CALCULATION; CONGENITAL ADRENAL HYPERPLASIA; CONTROLLED STUDY; FILTER; GESTATIONAL AGE; HUMAN; INFANT; MAJOR CLINICAL STUDY; NEWBORN; PAPER; PREDICTION; PRIORITY JOURNAL; REGRESSION ANALYSIS; RELIABILITY; SENSITIVITY AND SPECIFICITY;

17-ALPHA-HYDROXYPROGESTERONE; ADRENAL HYPERPLASIA, CONGENITAL; BIRTH WEIGHT; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; NEONATAL SCREENING; REGRESSION ANALYSIS; SENSITIVITY AND SPECIFICITY;

EID: 23044467470     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2004-2136     Document Type: Article

References (22)

1. Pang S, Shook MK 1997 Current status of neonatal screening for congenital adrenal hyperplasia. Curr Opin Pediatr 9:419-423
2. Hingre RV, Gross SJ, Hingre KS, Mayes DM, Richman RA 1994 Adrenal steroidogenesis in very low birth weight preterm infants. J Clin Endocrinol Metab 78:266-270
3. Larsson A, Thilén A, Hagenfeldt L, Döbeln von U, Guthenberg C 1992 Screening of half a million Swedish newborn infants for congenital adrenal hyperplasia. Screen 1:159-166
4. Allen DB, Hoffman GL, Fitzpatrick P, Laessig R, Maby S, Slyper A 1997 Improved precision of newborn screening for congenital adrenal hyperplasia using weight-adjusted criteria for 17-hydroxyprogesterone levels. J Pediatr 130:128-133
5. Torresani T, Gruters A, Scherz R, Burckhardt JJ, Harras A, Zachmann M 1994 Improving the efficacy of newborn screening for congenital adrenal hyperplasia by adjusting the cut-off level of 17α-hydroxyprogesterone to gestational age. Screen 3:77-84
6. Cutfield WS, Webster D 1995 Newborn screening for congenital adrenal hyperplasia in New Zealand. J Pediatr 126:118-121
7. Thompson R, Seargeant L, Winter JS 1989 Screening for congenital adrenal hyperplasia: distribution of 17 α-hydroxyprogesterone concentrations in neonatal blood spot specimens. J Pediatr 114:400-404
8. Therrell BL, Berenbaum SA, Manter-Kapanke V, Simmank J, Korman K, Prentice L, Gonzalez J, Gunn S 1998 Results of screening 1.9 million Texas newborns for 21-hydroxylase-deficient congenital adrenal hyperplasia. Pediatrics 101:583-590
9. Herngreen WP 1992 SMOCC: Design of a Representative Cohort-study of Live-born Infants in the Netherlands. Eur J Public Health 2:117-122
10. Cole TJ, Green PJ 1992 Smoothing reference centile curves: the LMS method and penalized likelihood. Stat Med 11:1305-1319
11. Midgley PC, Russell K, Oates N, Shaw JC, Honour JW 1996 Activity of the adrenal fetal zone in preterm infants continues to term. Endocr Res 22:729-733
12. al Saedi S, Dean H, Dent W, Cronin C 1995 Reference ranges for serum cortisol and 17-hydroxyprogesterone levels in preterm infants. J Pediatr 126:985-987
13. Verloove-Vanhorick SP, Verwey RA, Brand R, Gravenhorst JB, Keirse MJ, Ruys JH 1986 Neonatal mortality risk in relation to gestational age and birthweight. Results of a national survey of preterm and very-low-birthweight infants in the Netherlands. Lancet 1:55-57
14. Price HV, Cone BA, Keogh M 1971 Length of gestation in congenital adrenal hyperplasia. J Obstet Gynaecol Br Commonw 78:430-434
15. Bergstrand CG 1966 Growth in congenital adrenal hyperplasia. Acta Paediatr Scand 55:463-472
16. Qazi QH, Thompson WM 1971 Birthweight in congenital virilizing adrenal hyperplasia. Arch Dis Child 46:350-352
17. Jaaskelainen J, Voutilainen R 1997 Growth of patients with 21-hydroxylase deficiency: an analysis of the factors influencing adult height. Pediatr Res 41:30-33
18. al Saedi S, Dean H, Dent W, Stockl E, Cronin C 1996 Screening for congenital adrenal hyperplasia: the Delfia Screening Test overestimates serum 17-hydroxyprogesterone in preterm infants. Pediatrics 97:100-102
19. Minutti CZ, Lacey JM, Magera MJ, Houn Hahn S, McCann M, Schulze A, Cheillan D, Dorche C, Chace DH, Lymp JF, Zimmerman D, Rinaldo P, Matern D 2004 Steroid profiling by tandem mass spectrometry improves the positive predictive value of newborn screening for congenital adrenal hyperplasia. J Clin Endocrinol Metab 89:3687-3693
20. Nordenstrom A, Thilen A, Hagenfeldt L, Larsson A, Wedell A 1999 Genotyping is a valuable diagnostic complement to neonatal screening for congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency. J Clin Endocrinol Metab 84:1505-1509
21. Pang S 2003 Newborn screening for congenital adrenal hyperplasia. Pediatr Ann 32:516-523
22. Fitness J, Dixit N, Webster D, Torresani T, Pergolizzi R, Speiser PW, Day DJ 1999 Genotyping of CYP21, linked chromosome 6p markers, and a sex-specific gene in neonatal screening for congenital adrenal hyperplasia. J Clin Endocrinol Metab 84:960-966